Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

Share Price is delayed by 15 minutes
Get Live Data
305.00    -3.00 (-0.97%)
Bid:
291.00
Ask:
305.00
Spread: 14.00 (4.811%)
Market Cap: £161.65m
MAJE Live PriceLast checked at - London Stock Exchange

Intraday Majedie Inv. Share Chart

Kepler Trust Intelligence: New Research

3 Mar 2025 07:00

RNS Number : 9444Y
Majedie Investments PLC
03 March 2025
 

Majedie Investments: New Research

03/03//2025

MAJE offers exposure to differentiated sources of returns…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEVLFLELLFBBK
Date   Source Headline
1st Jun 202610:15 amRNSTotal Voting Rights
28th May 20267:00 amRNSHalf-year Financial Report
26th May 20263:04 pmRNSMid-Month Estimated Net Asset Value (NAV)
26th May 20263:02 pmRNSFinal Net Asset Value (NAV)
11th May 20263:45 pmRNSInvestor Event
11th May 20261:25 pmRNSEstimated Net Asset Value
1st May 202610:57 amRNSTotal Voting Rights
29th Apr 202610:00 amRNSDividend Declaration
29th Apr 20269:50 amRNSDirector Declaration
27th Apr 20263:56 pmRNSMid-Month Estimated Net Asset Value
27th Apr 20263:55 pmRNSFinal Net Asset Value
13th Apr 20263:47 pmRNSEstimated Net Asset Value
1st Apr 20268:49 amRNSTotal Voting Rights
25th Mar 20262:46 pmRNSMid-Month Estimated Net Asset Value
25th Mar 20262:41 pmRNSFinal Net Asset Value
10th Mar 20263:06 pmRNSEstimated Net Asset Value (NAV)
2nd Mar 20269:25 amRNSTotal Voting Rights
25th Feb 20263:56 pmRNSMid-Month Estimated Net Asset Value
25th Feb 20263:55 pmRNSFinal Net Asset Value
18th Feb 20264:26 pmRNSResult of AGM
10th Feb 20264:57 pmRNSEstimated Net Asset Value (NAV)
2nd Feb 20269:54 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSDividend Declaration
26th Jan 20264:33 pmRNSMid-Month Estimated Net Asset Value
26th Jan 20264:31 pmRNSFinal Net Asset Value
12th Jan 20265:29 pmRNSEstimated Net Asset Value
2nd Jan 20269:36 amRNSTotal Voting Rights
23rd Dec 20251:30 pmRNSMid-Month Estimated Net Asset Value
23rd Dec 20251:27 pmRNSFinal Net Asset Value
22nd Dec 20257:00 amRNSAnnual Financial Report
22nd Dec 20257:00 amRNSAnnual Financial Report
16th Dec 20254:11 pmRNSBlock listing Interim Review
10th Dec 20253:37 pmRNSEstimated Net Asset Value
1st Dec 202510:13 amRNSTotal Voting Rights
25th Nov 20253:50 pmRNSMid-Month Estimated Net Asset Value
25th Nov 20253:48 pmRNSFinal Net Asset Value
21st Nov 20255:09 pmRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSFurther re Marylebone Partners and Brown Advisory
10th Nov 20253:12 pmRNSEstimated Net Asset Value
3rd Nov 202511:28 amRNSTotal Voting Rights
31st Oct 20257:00 amRNS-RKepler Trust Intelligence: New Research
30th Oct 20257:00 amRNSDividend Declaration
24th Oct 20252:34 pmRNSMid-Month Estimated Net Asset Value
24th Oct 20252:29 pmRNSFinal Net Asset Value
24th Oct 202511:44 amRNSDirector/PDMR Shareholding
24th Oct 202511:41 amRNSDirector/PDMR Shareholding
10th Oct 20253:46 pmRNSEstimated Net Asset Value
1st Oct 20259:35 amRNSTotal Voting Rights
25th Sep 20253:32 pmRNSMid-Month Estimated Net Asset Value
25th Sep 20253:31 pmRNSFinal Net Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.